Paper7979239
Steroid 5 alpha-reductase: two genes/two enzymes.
Russell DW and 1 other. Annu Rev Biochem, 1994. Cited by 873 papers, by iCite.
Cite this record
ConductScience Library. Steroid 5 alpha-reductase: two genes/two enzymes. Papers, record 7979239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7979239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | Major topic |
| Isoenzymes | Major topic |
| 5-alpha Reductase Inhibitors | |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| DNA, Complementary | |
| Gene Expression Regulation, Enzymologic | |
| Humans | |
| Molecular Sequence Data | |
| Sequence Homology, Amino Acid |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DK03892 | NIDDK NIH HHS | United States | R01DK003892 | PubMed and NIH | NIH RePORTER |
| GM43753 | NIGMS NIH HHS | United States | R01GM043753 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00490555 | PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue | Background |
Source ClinicalTrials.gov
Cited by265
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 873 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42856873 | Clinical characteristics and genotype-phenotype correlation analysis in 279 patients with 5α-reductase type 2 deficiency. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42856873 | PubMed |
| 42552333 | Exonisation of an Alu element in the 3'-UTR contributes to SRD5A2 deficiency. | Sci Rep | 2026 | https://conductscience.org/library/papers/42552333 | PubMed |
| 42547757 | Absence of Interaction Between 5α-Reductase Inhibitors and Glucocorticoids on Incidence of Myocardial Infarction in People With Type 2 Diabetes. | Diabetes Obes Metab | 2026 | https://conductscience.org/library/papers/42547757 | PubMed |
| 42492846 | Steroid 5α-reductases in the brain: From neurosteroidogenesis to therapeutic implications. | Front Neuroendocrinol | 2026 | https://conductscience.org/library/papers/42492846 | PubMed |
| 42095272 | Serum androgen profile of elite athletes. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42095272 | PubMed |
| 41938679 | Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging. | Cureus | 2026 | https://conductscience.org/library/papers/41938679 | PubMed |
| 41735769 | Androgen metabolism in prostate cancer: recent advances. | Endocrinology | 2026 | https://conductscience.org/library/papers/41735769 | PubMed |
| 41501168 | SRD5A2 and emerging therapies in androgen-driven disorders. | Nat Rev Urol | 2026 | https://conductscience.org/library/papers/41501168 | PubMed |
| 41158964 | Integrated management strategies for benign prostatic hyperplasia. | Front Urol | 2025 | https://conductscience.org/library/papers/41158964 | PubMed |
| 40985611 | Hepatic KLF9 Deficiency Inhibits Dehydroepiandrosterone (DHEA)-Induced Polycystic Ovary Syndrome via Liver-Ovary Axis. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40985611 | PubMed |
| 40893303 | Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, In Vitro, and In Silico Studies. | ACS Omega | 2025 | https://conductscience.org/library/papers/40893303 | PubMed |
| 40600011 | The role of adipose tissue in puberty and reproductive health. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40600011 | PubMed |
| 40286110 | Kyoh® Rocket Leaf Extract Regulates Proliferation and VEGF and FGF7 Expression in Human Dermal Follicle Papilla Cells. | Molecules | 2025 | https://conductscience.org/library/papers/40286110 | PubMed |
| 40164759 | Differential association between cumulative dose of 5α-reductase inhibitors and mortality. | Sci Rep | 2025 | https://conductscience.org/library/papers/40164759 | PubMed |
| 40127205 | Inhibition of Steroidogenesis in Prostate Cancer Cells by Both a Natural and Another Synthetic Steroid. | Drug Dev Res | 2025 | https://conductscience.org/library/papers/40127205 | PubMed |
| 40079157 | 3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials. | Future Med Chem | 2025 | https://conductscience.org/library/papers/40079157 | PubMed |
| 40043094 | Novel non-synonymous and synonymous gene variants of SRD5A2 in patients with 46,XY-DSD and DSD-free subjects. | PLoS One | 2025 | https://conductscience.org/library/papers/40043094 | PubMed |
| 39841836 | Prefrontal 5α-reductase 2 mediates male-specific acute stress response. | Sci Adv | 2025 | https://conductscience.org/library/papers/39841836 | PubMed |
| 39223181 | A comparative study of histotripsy parameters for the treatment of fibrotic ex-vivo human benign prostatic hyperplasia tissue. | Sci Rep | 2024 | https://conductscience.org/library/papers/39223181 | PubMed |
| 39201544 | 5β-Dihydrosteroids: Formation and Properties. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201544 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7979239
GET https://conductscience.org/api/papers/v1/7979239/cited_by?page=2